NPPA fixes retail prices of 25 drug formulations
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) on Monday said that it has fixed the retail prices of 25 new drug formulations.
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) on Monday said that it has fixed the retail prices of 25 new drug formulations. Companies will issue new prices through Form-V from the date of notification and inform the entire dealership to the public.
All retailers and dealers will have to put up a new rate list. If a company fails to do so, then the company will have to deposit the extra amount charged with interest in DPCO.
"In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955," the official notification read.
Also read- Income Tax slabs, rates and exemptions for senior citizens: Know how income tax on pension is calculated
Other companies include Aristo Pharma, Wockhardt, Cipla, Glenmark Pharma, Zydus Healthcare, Lupin, Torrent, Mankind, Alembic, Sun Pharma and Abbott, among others.
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.